Study to Evaluate the QT / QTc Interval Prolongation Potential of Vericiguat

Clinical trial NCT03504982 · COMPLETED

Trial details

NCT number: NCT03504982
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2018-05-17
Primary completion: 2018-11-29
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.